Transcriptome changes in age-related macular degeneration

BMC Medicine

Robert F Mullins¹  S Scott Whitmore² 

[1] Department of Ophthalmology and Visual Sciences, The University of Iowa Carver College of Medicine, 4135E MERF, 375 Newton Rd., Iowa City, IA 52242, USA;Center for Bioinformatics and Computational Biology, The University of Iowa, 5315 SC, 103 South Capitol St., Iowa City, IA 52242, USA

关键词: systems biology;    transcriptome;    age-related macular degeneration;   

Others  :  1126332
DOI  :  10.1186/1741-7015-10-21

 received in 2012-02-09, accepted in 2012-02-27,  发布年份 2012

【 摘 要 】

Age-related macular degeneration (AMD) is a debilitating, common cause of visual impairment. While the last decade has seen great progress in understanding the pathophysiology of AMD, the molecular changes that occur in eyes with AMD are still poorly understood. In the current issue of Genome Medicine, Newman and colleagues present the first systematic transcriptional profile analysis of AMD-affected tissues, providing a comprehensive set of expression data for different regions (macula versus periphery), tissues (retina versus retinal pigment epithelium (RPE)/choroid), and disease state (control versus early or advanced AMD). Their findings will serve as a foundation for additional systems-level research into the pathogenesis of this blinding disease.

Please see related article: http://genomemedicine.com/content/4/2/16 webcite

【 授权许可】

   
2012 Whitmore and Mullins; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Klein R, Chou C-F, Klein BEK, Zhang X, Meuer SM, Saaddine JB: Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol 2011, 129:75-80.
• [2]Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, Curletti CR, Hancox LS, Hu J, Ebright JN, Malek G, Hauser MA, Rickman CB, Bok D, Hageman GS, Johnson LV: The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 2010, 29:95-112.
• [3]Wang Y, Wang VM, Chan CC: The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment. Eye 2011, 25:127-139.
• [4]Khandhadia S, Lotery A: Oxidation and age-related macular degeneration: insights from molecular biology. Expert Rev Mol Med 2010, 12:e34.
• [5]Age-Related Eye Disease Study Research Group: A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001, 119:1417-1436.
• [6]Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT: Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994, 272:1413-1420.
• [7]Booij JC, ten Brink JB, Swagemakers SMA, Verkerk AJMH, Essing AHW, van der Spek PJ, Bergen AAB: A new strategy to identify and annotate human RPE-specific gene expression. PLoS ONE 2010, 5:e9341.
• [8]Strunnikova NV, Maminishkis A, Barb JJ, Wang F, Zhi C, Sergeev Y, Chen W, Edwards AO, Stambolian D, Abecasis G, Swaroop A, Munson PJ, Miller SS: Transcriptome analysis and molecular signature of human retinal pigment epithelium. Hum Mol Genet 2010, 19:2468-2486.
• [9]Ishibashi K, Tian J, Handa JT: Similarity of mRNA phenotypes of morphologically normal macular and peripheral retinal pigment epithelial cells in older human eyes. Invest Ophthalmol Vis Sci 2004, 45:3291-3301.
• [10]Diehn JJ, Diehn M, Marmor MF, Brown PO: Differential gene expression in anatomical compartments of the human eye. Genome Biol 2005, 6:R74. BioMed Central Full Text
• [11]Bowes Rickman C, Ebright JN, Zavodni ZJ, Yu L, Wang T, Daiger SP, Wistow G, Boon K, Hauser MA: Defining the human macula transcriptome and candidate retinal disease genes using EyeSAGE. Invest Ophthalmol Vis Sci 2006, 47:2305-2316.
• [12]van Soest SS, de Wit GMJ, Essing AHW, ten Brink JB, Kamphuis W, de Jong PTVM, Bergen AAB: Comparison of human retinal pigment epithelium gene expression in macula and periphery highlights potential topographic differences in Bruch's membrane. Mol Vis 2007, 13:1608-1617.
• [13]Radeke MJ, Peterson KE, Johnson LV, Anderson DH: Disease susceptibility of the human macula: differential gene transcription in the retinal pigmented epithelium/choroid. Exp Eye Res 2007, 85:366-380.
• [14]Newman AM, Gallo NB, Hancox LS, Miller NJ, Radeke CM, Maloney MA, Cooper JB, Hageman GS, Anderson DH, Johnson LV, Radeke MJ: Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Med 2012, 4:16. BioMed Central Full Text
• [15]Hornshøj H, Bendixen E, Conley LN, Andersen PK, Hedegaard J, Panitz F, Bendixen C: Transcriptomic and proteomic profiling of two porcine tissues using high-throughput technologies. BMC Genomics 2009, 10:30. BioMed Central Full Text
• [16]Nordgaard CL, Berg KM, Kapphahn RJ, Reilly C, Feng X, Olsen TW, Ferrington DA: Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci 2006, 47:815-822.
• [17]Ethen CM, Reilly C, Feng X, Olsen TW, Ferrington DA: The proteome of central and peripheral retina with progression of age-related macular degeneration. Invest Ophthalmol Vis Sci 2006, 47:2280-2290.
• [18]Gu J, Pauer GJT, Yue X, Narendra U, Sturgill GM, Bena J, Gu X, Peachey NS, Salomon RG, Hagstrom SA, Crabb JW, Clinical Genomic and Proteomic AMD Study Group: Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers. Mol Cell Proteomics 2009, 8:1338-1349.
• [19]Soreq L, Bergman H, Israel Z, Soreq H: Exon arrays reveal alternative splicing aberrations in Parkinson's disease leukocytes. Neurodegener Dis, in press.
• [20]Mercer TR, Gerhardt DJ, Dinger ME, Crawford J, Trapnell C, Jeddeloh JA, Mattick JS, Rinn JL: Targeted RNA sequencing reveals the deep complexity of the human transcriptome. Nat Biotechnol 2011, 30:99-104.
• [21]Wang G-S, Cooper TA: Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 2007, 8:749-761.
• [22]Ezzat M-K, Hann CR, Vuk-Pavlovic S, Pulido JS: Immune cells in the human choroid. Br J Ophthalmol 2008, 92:976-980.
• [23]Mullins RF, Johnson MN, Faidley EA, Skeie JM, Huang J: Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci 2011, 52:1606-1612.
• [24]Swaroop A, Chew EY, Rickman CB, Abecasis GR: Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet 2009, 10:19-43.
• [25]Hecker LA, Edwards AO: Genetic control of complement activation in humans and age related macular degeneration. In Inflammation and Retinal Disease: Complement Biology and Pathology. Edited by Lambris JD, Adamis AP. New York: Springer; 2010:49-62. [Advances in Experimental Medicine and Biology, vol 703.]
• [26]Mullins RF, Dewald AD, Streb LM, Wang K, Kuehn MH, Stone EM: Elevated membrane attack complex in human choroid with high risk complement factor H genotypes. Exp Eye Res 2011, 93:565-567.